The start of the easing of the restrictions on lockdown has focused many minds on recommencing M&A activity that may have been placed on pause in the initial "survival" phase. This is certainly a great time for many to look at opportunities that exist in this emerging landscape.
Corporate winners (and losers) will emerge from lockdown. More so than ever, a company might prosper because it operates in the right sector (healthcare and life sciences spring to mind). Or, it has pockets deep enough to weather the storm or the foresight to understand before its rivals how its market has altered (perhaps because of changes in consumer behaviour, supply chains or route to market). While not without risk, such companies can capitalise on their advantages with a bold M&A strategy.